Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ETOPOSIDE for B-cell lymphoma refractory: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 49 adverse event reports in the FDA FAERS database where ETOPOSIDE was used for B-cell lymphoma refractory.

Most Reported Side Effects for ETOPOSIDE

Side Effect Reports % Deaths Hosp.
Off label use 6,495 12.4% 1,541 2,054
Febrile neutropenia 5,966 11.3% 834 3,249
Disease progression 3,776 7.2% 1,088 522
Drug ineffective 3,687 7.0% 1,234 1,065
Neutropenia 3,641 6.9% 587 1,212
Thrombocytopenia 3,085 5.9% 570 1,146
Product use in unapproved indication 2,774 5.3% 629 648
Anaemia 2,586 4.9% 376 1,163
Pyrexia 2,453 4.7% 405 1,551
Sepsis 2,211 4.2% 1,140 958
Pancytopenia 2,129 4.1% 462 1,045
Nausea 1,795 3.4% 229 927
Death 1,697 3.2% 1,692 249
Pneumonia 1,684 3.2% 705 873
Diarrhoea 1,627 3.1% 335 865

Other Indications for ETOPOSIDE

Diffuse large b-cell lymphoma (4,698) Product used for unknown indication (3,071) Small cell lung cancer (2,514) Hodgkin's disease (2,252) Acute lymphocytic leukaemia (1,637) Plasma cell myeloma (1,449) Non-hodgkin's lymphoma (1,380) Acute myeloid leukaemia (1,374) Small cell lung cancer extensive stage (1,336) B-cell lymphoma (1,268)

Other Drugs Used for B-cell lymphoma refractory

RITUXIMAB (103) OBINUTUZUMAB (84) CISPLATIN (53) DEXAMETHASONE (45) AXICABTAGENE CILOLEUCEL (44) CYCLOPHOSPHAMIDE (43) CYTARABINE (40) IBRUTINIB (39) LENALIDOMIDE (36) GEMCITABINE (33)

Related Pages

ETOPOSIDE Full Profile All B-cell lymphoma refractory Drugs ETOPOSIDE Demographics ETOPOSIDE Timeline